# Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19

> **NCT05142527** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Alachua Government Services, Inc.**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** ADM03820
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05142527
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01
- **Primary completion:** 2024-01
- **Final completion:** 2024-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrew study prior to initiation and no participants were enrolled.
- **Last updated:** 2023-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142527, "Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05142527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*